Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3834721)

Published in Postepy Dermatol Alergol on June 20, 2013

Authors

Katarzyna Gutfreund1, Wojciech Bienias, Anna Szewczyk, Andrzej Kaszuba

Author Affiliations

1: Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Poland. Head: Prof. Andrzej Kaszuba MD, PhD.

Associated clinical trials:

Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients | NCT02864498

Articles citing this

Patchy alopecia areata sparing gray hairs: a case series. Postepy Dermatol Alergol (2014) 0.75

Articles cited by this

Glaucoma from topical corticosteroids to the eyelids. Clin Experiment Ophthalmol (2004) 2.03

Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77

Tacrolimus: the drug for the turn of the millennium? Arch Dermatol (1999) 1.69

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol (2004) 1.53

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol (2002) 1.23

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 1.22

Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National Health Service) perspective. Br J Dermatol (2011) 1.20

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol (2004) 1.08

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr (2003) 1.08

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm (2004) 1.07

Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol (2001) 0.98

The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. Br J Dermatol (2007) 0.95

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol (2005) 0.95

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 0.93

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93

Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome. Arch Ophthalmol (2009) 0.92

Proactive therapy of atopic dermatitis--an emerging concept. Allergy (2008) 0.89

Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol (2002) 0.88

Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application. Drug Metab Dispos (2008) 0.87

Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy (2006) 0.85

Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract (2005) 0.84

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol (2005) 0.84

The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol (2007) 0.84

Clinical controversy on the effect of topical ciclosporin: what is the target site? Dermatology (1992) 0.83

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol (2007) 0.82

Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study. Int J Dermatol (2011) 0.82

A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Br J Dermatol (2008) 0.82

Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol (2008) 0.80

Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Arch Dis Child (2006) 0.79

[Topical cyclosporine in the treatment of oral pemphigus]. Minerva Stomatol (1998) 0.77

Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. Acta Derm Venereol (2006) 0.77

Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol (2002) 0.77

Articles by these authors

[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies]. Postepy Hig Med Dosw (Online) (2007) 0.91

Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. Am J Clin Dermatol (2011) 0.91

The use of spa and phage typing for characterization of clinical isolates of methicillin-resistant Staphylococcus aureus in the University Clinical Center in Gdańsk, Poland. Folia Microbiol (Praha) (2012) 0.81

Efficacy and safety of the freeze-dried cultured human keratinocyte lysate, LyphoDerm 0.9%, in the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen (2005) 0.81

[Age-related macular degeneration--a complex genetic disease]. Klin Oczna (2008) 0.81

Systemic contact dermatitis to nickel present in cocoa in 14-year-old boy. Pediatr Dermatol (2011) 0.80

In psoriasis, levels of hope and quality of life are linked. Arch Dermatol Res (2014) 0.79

A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial. J Cosmet Dermatol (2011) 0.75

The potential of use basil and rosemary essential oils as effective antibacterial agents. Molecules (2013) 0.75

Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients. Pharmacol Rep (2009) 0.75

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials. J Drugs Dermatol (2016) 0.75

[Factors forming opnion on marijuana legalization in Poland among group of students from medical and technical college faculty]. Przegl Lek (2015) 0.75